Literature DB >> 8909289

HIV-1 gp41 tertiary structure studied by EPR spectroscopy.

M D Rabenstein1, Y K Shin.   

Abstract

HIV gp41 is the transmembrane glycoprotein responsible for fusion of viral and cellular membranes, enabling viral entry. The structure of gp41 was studied using two synthetic peptides derived from the ectodomain of gp41: a 38-residue peptide from the "heptad repeat" region (hr.wt), and a 34-residue peptide from a region closer to the C-terminus (bt wt). These peptides were found to form a trimer of heterodimers with approximately 80% alpha-helicity. To study their alignment, distances between spin-labels attached to Cys residues on Cys-substituted peptides were measured using a recently-developed electron paramagnetic resonance method [Rabenstein, M.D., & Shin, Y.-K. (1995) Proc Natl. Acad. Sci. U.S.A. 92, 8239-8243]. The heterotrimeric peptides were found to be antiparallel, consistent with a study on proteolytically cleaved peptide fragments of gp41 [Lu, M., Blacklow, S.C., & Kim, P.S. (1995) Nat. Struct. Biol. 2, 1075-1082]. Furthermore, the C-terminal 19 residues of hr.wt are not apposed to bt.wt, and 15 residues of bt.wt extend beyond the end of br.wt. Consistent with this alignment are tertiary interactions between specific sites of these peptides probed by spin-label mobility. Additionally, a second pair of peptides was studied. From the model, these are expected to align with complete overlap. Alone, neither was helical, but when mixed, they were 83% helical. Based on the alignment of the peptides, a model of the prefusogenic form of gp41 was constructed which is significantly different from the structure of influenza hemagglutinin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8909289     DOI: 10.1021/bi961743t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41.

Authors:  M Caffrey; M Cai; J Kaufman; S J Stahl; P T Wingfield; D G Covell; A M Gronenborn; G M Clore
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

2.  Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli.

Authors:  W Weissenhorn; L J Calder; A Dessen; T Laue; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

3.  Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.

Authors:  S S Chen; S F Lee; H J Hao; C K Chuang
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  A novel 5 displacement spin-labeling technique for electron paramagnetic resonance spectroscopy of RNA.

Authors:  J C Macosko; M S Pio; I Tinoco; Y K Shin
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

5.  Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

Authors:  L T Rimsky; D C Shugars; T J Matthews
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism.

Authors:  J K Judice; J Y Tom; W Huang; T Wrin; J Vennari; C J Petropoulos; R S McDowell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.

Authors:  Yael Wexler-Cohen; Yechiel Shai
Journal:  PLoS Pathog       Date:  2009-07-10       Impact factor: 6.823

8.  Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS.

Authors:  D C Adamson; J C McArthur; T M Dawson; V L Dawson
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.